Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Cancer
    • Enhancement of tissue...

    Enhancement of tissue on breast MRI an indicator of breast cancer

    Written by Medha Baranwal Baranwal Published On 2019-01-27T19:10:09+05:30  |  Updated On 27 Jan 2019 7:10 PM IST
    Enhancement of tissue on breast MRI an indicator of breast cancer

    USA: Increased levels of background parenchymal enhancement (BPE) on breast MRI is associated with an increased risk of future invasive breast cancer independent of the breast density, according to a new study published in the Journal of Clinical Oncology.


    Vignesh A. Arasu, Kaiser Permanente Medical Center, Vallejo, CA, and colleagues conducted the study to evaluate comparative associations of breast magnetic resonance imaging BPE and mammographic breast density with subsequent risk of breast cancer.


    The combination of elevated BPE and dense breast tissue increases a woman's overall risk for breast cancer more than either factor on its own, write the authors.


    "Among women undergoing screening or diagnostic breast MRI, elevated levels of BPE significantly increased risk of developing primary invasive breast cancer," the group wrote. "BPE had a stronger association with breast cancer risk than breast density in this population. Moreover, BPE was independent of breast density in risk prediction, and the combination of BPE and breast density increased the overall risk for breast cancer more than either factor alone."


    The study included 4,247 women undergoing breast MRI in facilities participating in the Breast Cancer Surveillance Consortium (BCSC) from 2005 to 2015. The women's BPE was assessed at the time of interpretation of the breast MRI exam. The team used mammography results performed within five years of the MRI scans to assess the women's breast tissue density and risk factors. The group estimated hazard ratios for breast cancer using a BCSC model.


    Also Read: Statins decrease mortality risk in Breast Cancer, confirms study

    Key Findings:

    • Among the 4,247 women included, 176 developed breast cancer over a median follow-up period of 2.8 years. Of these cancers, 129 were invasive (73%) and 47 were ductal carcinoma in situ (27%).

    • More women with cancer had mild, moderate, or marked BPE than women without cancer (80% v 66%, respectively).

    • Compared with minimal BPE, increasing BPE levels were associated with significantly increased cancer risk.

    • Compared with women with minimal BPE and almost entirely fatty or scattered fibroglandular breast density, women with mild, moderate, or marked BPE demonstrated elevated cancer risk if they had almost entirely fatty or scattered fibroglandular breast density or heterogeneous or extremely dense breasts, with no significant interaction.

    • Combined mild, moderate, and marked BPE demonstrated significantly increased risk of invasive cancer but not ductal carcinoma in situ.


    Also Read: Childbirth increases breast cancer risk in young women

    "BPE offers a promising way to predict future breast cancer risk," the authors concluded, suggesting that, "BPE should be considered for incorporation into risk prediction models for women undergoing MRI."


    For further reference log on to https://doi.org/10.1200/JCO.18.00378
    Breastbreast cancerbreast cancer riskbreast densitybreast MRIdense breastsfibroglandular tissueinvasive breast cancerJournal of Clinical Oncologymagnetic resonance imagingmammographic breast densitytissue enhancementVignesh Arasu
    Source : With inputsf from Journal of Clinical Oncology

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok